We build the partnership ecosystems that help platforms scale.
Currently focused on GLP-1 and metabolic health, where growth is shifting from access to retention, outcomes and partnerships.
Our view
GLP-1 telehealth is no longer constrained by demand. The value now sits in keeping patients engaged. Telehealth platforms own the patient relationship, pharma owns supply and data, and payers fund the outcomes. The winners will be the ones who align all three:
Pharma preferred-channel and outcomes-based coaching agreements with telehealth platforms
Daily-engagement, wearables and data infrastructure that improves retention and outcomes
Payer partnerships that fund the full patient journey
Adjacent retail and wellness cross-sell, since GLP-1 patients create new footfall and basket uplift
What we do
Ecosystem partnership strategy and origination: pharma, telehealth, payer and data partnerships in regulated, multi-stakeholder markets
Business development: senior relationships, creative propositions and business cases to drive growth
Portfolio management, Board representation and reporting: for investors who own, or aspire to own, assets in the UK or India
Track record
Platform ecosystem partnerships across automotive, subscription and loyalty at Uber EMEA, across $10bn of gross bookings
Originated and closed a £450m EV coalition aligning energy, financial services and competing OEMs around one commercial structure
OEM and AV ecosystem partnerships across Europe
Portfolio and board experience in the UK and Asia with Virgin Management, HT Media, Mumbai Angels, HSBC Private Equity and Astro
Founded by Gul Mukhey to help high-potential growth businesses scale through partnerships, governance and funding.
If you’re building, investing in or partnering on GLP-1 or metabolic health platforms, connect with Gul on LinkedIn
Add elementPaste